Sie sind hier: Programm > Postersessions - Thursday, Dec. 1st, 2016

Poster Session I - Thursday, December 1st, 2016

 
Lecture Hall Pavillon
 

 13.45-15.45

Aortic diseases

Introducing lecture:
Options for late complications after surgery for aortic coarctation

 

C. Dzsinich,
Budapest, Hungary

      P 03

Pathogenically-based pharmacological stabilization of abdominal aortic aneurysm growth – a one year study

 

A. Nykonenko,
Zaporozhye, Ukraine

      P 04

Management of floating thrombus in the aortic arch

 

R. Bühlmann,
Bern, Switzerland

      P 06

Descendo-bifemoral bypass grafting and renal artery revascularization to treat complex obliterative arteriopathy

 

S. Kondov,
Freiburg, Germany

      P 08

Neutrophil subsets and activation markers are sensitive diagnostic indicators of the abdominal aortic aneurysm

 

B. Zagrapan,
Vienna, Austria

      P 11

Animal experiment: Conservative treatment of prosthetic vascular graft infection caused by Staphylococcus aureus

 

E. Staneviciute,
Vilnius, Lithuania

      P 12

Small abdominal aortic aneurysm ruptures – potential risk factors identification and new way of rupture risk prediction based on finite element method

 

L. Kubicek,
Brno, Czech Republic

      P 14

Salmonella aortitis

 

V. Treska,
Plzen, Czech Republic

      P 16

How does the descending aorta geometry change when it dissects?

 

B. Rylski,
Freiburg, Germany

      P 19

Case report: An alternative material in treatment of vascular prosthetic graft infection

 

H. Järve,
Tartu, Estonia

      P 21

Downstream remodeling of the aorta after the frozen elephant trunk repair of arch and descending aortic aneurysms

 

M. Kreibich,
Freiburg, Germany

        P 22

Single center experience with orthotopic pericardial tube graft replacement of infected abdominal aortic grafts

 

M. Kreibich,
Freiburg, Germany

      P 23

Follow-up of small abdominal aortic aneurysms using 3D-ultrasound: volume versus diameter

 

Q. M. Ghulam,
Copenhagen, Denmark

      P 24

Early and late failure of EVAR – surgical and endovascular solution

 

J. Molacek,
Plzen, Czech Republic

      P 27

MicroRNA-29b ia a regulator and therapeutic target of aortic stiffness in Type 2 Diabetes

 

I. N. Schellinger,
Göttingen, Germany

      P 29

Inflammatory abdominal aortic aneurysm and early postoperative outcomes after open-surgery: a 10-year single-center experience

 

N. Floros,
Düsseldorf, Germany

      P 31

3-D Modeling (rapid prototyping) of the abdominal aorta for experimental endovascular navigation

 

M. Kleemann,
Lübeck, Germany

      P 40

Female sex is an independent risk factor for worse clinical outcomes in AAA treatment in Germany

 

M. Trenner,
Munich, Germany

      P 41

Simulator Training for Complex Endovascular Procedures

 

J. Falkensammer,
Vienna, Austria

      P 42

Does the graft design determine the AAA shrinkage rate?
Single center 12-36 month Follow up data of the new TREOVANCE device for AAA repair show a durable exclusion with an unexpected high shrinkage rate
 

 

J. Tessarek,
Lingen, Germany

 

Each poster: 3 minutes presentation + 3 minutes discussion